Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


April 19, 2015 7:54 AM ET

Biotechnology

Company Overview of 3-V Biosciences, Inc.

Executive Profile

Edward M. Connor Jr., M.D.

Former Director and Member of Compensation Committee, GenVec, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 Board Members in 0 different organizations across 4 different industries.

62$44,299

Background

Mr. Edward M. Connor, also known as Ed, Jr., MD serves as a Consultant of Pediatric Infectious Diseases. Dr. Connor served as the Chief Medical Officer at 3-V Biosciences, Inc. since June 2010. He served as the Chief Medical Officer of MedImmune, LLC since February 2004 until 2008 and its Executive Vice President of clinical development since October 19, 2004 until 2008. Dr. Connor had been responsible for directing all medical activities for MedImmune, which include ...

Corporate Headquarters

1050 Hamilton Court
Menlo Park, California 94025

United States

Phone: 650-561-8600
Fax: --

Board Members Memberships

Former Director
2011-2013
Former Director and Member of Compensation Committee

Education

Bachelor's Degree
Villanova University
MD
University of Pennsylvania - School of Medicine

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

Exercisable Options$17,500
Total Number of Options$17,500

Total Compensation

Total Annual Cash Compensation$44,299
Total Calculated Compensation$44,299
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jeffrey D. Abbey MBA, J.D.Chief Executive Officer, President and Director
Argos Therapeutics, Inc.
$543.6K
Vijay B. Samant Chief Executive Officer, President, Acting Chief Financial Officer and Director
Vical Incorporated
$821.0K
Hans Arwidsson Ph.D.Chief Executive Officer and President
Eurocine Vaccines AB
$1.1M
Daniel J. O'Connor Esq.Chief Executive Officer, President and Director
Advaxis, Inc.
$398.8K
William D. Clark Chief Executive Officer, President and Director
Genocea Biosciences, Inc.
$393.6K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact 3-V Biosciences, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.